Med-IQ Logo
Get CME/CE

Course Listings: Hematology

All Results (5)
Format: Live Events (0) Online Activities (5)

Improving Multiple Myeloma Care in a Rapidly Evolving Field

View Course

Format: Webcast

    Maximum Credits:
  • 1.0 AMA PRA Category 1 Credit(s)

Course Description: This CME Webcast explores clinical management strategies for multiple myeloma. Experts in the field use patient cases to discuss current clinical evidence and treatment guidelines for newly diagnosed and relapsed/refractory disease, with a focus on patient-, disease-, and treatment-related factors that guide therapeutic decisions.


Recognizing Gaucher’s Disease in the Hematology Clinic

View Course

Format: Presentation Points

    Maximum Credits:
  • 0.5 AMA PRA Category 1 Credit(s)

Course Description: This transcript-based, CME-certified Presentation Points publication summarizes a satellite symposium presented by Pramod K. Mistry, MD, PhD, FRCP, and Neal J. Weinreb, MD, FACP, nationally renowned experts in Gaucher’s disease (GD) type 1. Faculty present strategies for recognizing symptoms early in the disease course and discuss the implications of…More


Managing CLL With Oral Agents

View Course

Format: Webinar

    Maximum Credits:
  • 1.0 AMA PRA Category 1 Credit(s)
  • 1.0 California Board of Registered Nursing (CBRN)

Course Description: This activity brings together two nationally recognized experts to discuss the practical considerations of managing CLL with oral agents. It explores the benefits and challenges of oral CLL therapies, discusses strategies for monitoring and managing adverse events, and addresses barriers to adherence.


Prolonging Survival in Patients With Metastatic Colorectal Cancer Using Novel VEGF-Directed, Antiangiogenic Agents

View Course

Format: Med-IQ Express

    Maximum Credits:
  • 0.25 AMA PRA Category 1 Credit(s)

Course Description: This 15-minute publication begins with a brief video in which a clinical expert reviews the use of antiangiogenic agents in patients with progressive metastatic colorectal cancer (mCRC). The publication then presents key guideline recommendations and a focused discussion on pivotal trials of the 4 main agents used to prolong survival in patients with mCRC.


Managing CLL With Targeted Oral Agents: Educating and Empowering Patients to Improve Adherence

View Course

Format: E-publication

    Maximum Credits:
  • 0.5 AMA PRA Category 1 Credit(s)

Course Description: This CME publication addresses the practical considerations of using oral agents in the treatment of chronic lymphocytic leukemia. It reviews strategies for managing adverse events, discusses reasons for medication nonadherence, and offers tips for engaging patients and improving adherence to oral agents.